Lecture 5 - Dermatology 2 Flashcards

(88 cards)

1
Q

tell tale sign of psoriasis

A

erythematous papule and plaques with silver scale

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Psoriasis risk factors

A

Genetic predisposition
Environmental Triggers, infection, stress
Medications
Smoking
Obesity & higher BMI in adults and children
Vitamin D deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

exacerbating factors for psoriasis

A

Drugs = BB< lithium, antimalarial meds, ACEi, NSAIDs
Infections, bacterial and viral
Alcohol abuse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Exacerbating comorbidities for psoriasis

A

CVD
Malignancy
Diabetes
HTN
Metabolic syndrome
IBD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Patients with psoriasis are at increased risk for…..

A

CV events

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Clinical presentation of plaque psoriasis

A

symmetrically distributed plaques
*sharply defined margins raised above surrounding normal skin
Tick, silvery scale is usually present
Auspit’z sign
1-10cm in diameter
typically asymptomatic, may have itching

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Nail psoriasis

A

most often noted after onset of disease
involvement of nail Matrix or nail bed
nail pitting
Leukonychia
typically req system therapy or sublingual injections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How is severity of psoriasis assessed?

A

Based on %% of body surface area

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Desired outcomes of psoriasis?

A

minimize or eliminate signs of psoriasis
Alleviate pruritus if present
Reduce frequency & flare ups
Avoid/minimize ADE
cost effective therapy
approve QOL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Non-pharm psoriasis therapy

A

Stress reduction
Using moisturizers
Oatmeal baths
sunscreen 30+ SPF
Avoidance of irritants
Avoidance of offending agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Psoriasis: topical corticosteroid therapy

A

Mainstay of therapy
Location, age, plaque thickness taken into consideration
usually BID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Lower potency Topical steroid used for….

A

infants and lesions on the face, intertriginous areas (rub together) and area with thin skin

ex. Hydrocortisone 0.5-2.5% cream

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Mid-high potency topical steroid used for….

A

most areas generally recommended

ex. Betamethasone valerate 0.12% ointment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Ultra-High potency topical steroid use for….

A

very thick plaques or recalcitrant disease

ex. Clobetasol 0.05% cream

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Treatment of choice for mild-mod psoriasis…..

A

Topical corticosteroids

less ADR, QD-BID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Topical Vit D analogs info

A

inhibit keratinocyte proliferation and enhancement of keratinocyte differentiation

immunosuppressive properties

comparable to group 3 steroids, but more $$ & irritating

Calcitriol < Calcipotriene irritation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Vitamin D analog Safety

A

Photosensitivity and inc risk of UV-induced skin tumors
Acute psoriatic eruption of scalp can occur
topical solution and foam are flammable
Safe in peds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Vitamin D analog tolerability

A

Hypercalcemia is concern w/ higher doses (>100g/week)
can worsen psoriasis, cause skin irritation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Topical Vitamin D analog efficacy

A

Calcipotriene as effective as TCS but more ADR
Greatest efficacy when combo w/ betamethasone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Vitamin D analog clinical pearls

A

used in combo w/ TCS
inactivated by UVA, apply after not before exposure

BID application, not more than 30% BSA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Tazarotene info

A

Retinoid

limited absorption, but irritation is major issue and limits use

irritation is dose dependent

therapeutic benefit can persist up to 12weeks after stopping

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Tazarotene safety

A

Preg X
Photosensitivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Tazarotene Tolerability

A

Inc sensitivity to environmental factors
Skin burning, stinging, irritation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Tazarotene efficacy

A

50% improvement in symptoms at 12 weeks in 50% of treated pts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Tazarotene clinical pearls
used with TCS for inc efficacy and tolerability use lower strength cream and combo with moisturizer alternate days to reduce irritation used QD
26
Other treatment options for psoriasis
Anthralin = V irritating, have to do short contact regimen Coal Tar = stain and small, used at night Salicylic Acid = avoid combo w/ calcipqotriol, phototherapy, > 20% BSA, renal impairment, children
27
Using topical calcineurin inhibi for psoriasis
not FDA approved Not as effective so not really used
28
Excimer Laser
Faster responses Can cause tanned spots on skin high doses of UVA light to certain spots
29
Biologic agents used in which psoriasis patients
moderate to severe plaque type good short/long term
30
Enbrel (Etanercept)
Approved for PsA and moderate to severe psoriasis Give 50mg SQ BIW for 1st 12weeks, then 25/50mg QW efficacious children 4-17 dosed 0.8mg/kg (50mg max) QW
31
Humira (Adalimmab)
rapid and efficacious control of psoriasis and PsA, can see improvement in 1st week dose: 80mg SQ once, then 40mg SQ QOW effective alternative for pts who fail to respond to Enbrel
32
Remicade (Infliximab)
more efficacious than Entanercept Given Iv infusion over 6 weeks, then every 8 weeks Rapid response Rare but serious ADE = highest risk for TB, Bacterial/viral/invasive fungal infection, Fatal cases of hepatosplenic T-cell lymphomas
33
Cimzia (Certolizumab Pegol)
Dosed QOW Mild ADR = nasopharyngitis & URI $$$ relatively safe in pregnancy
34
TNF Alpha-inhibitors efficacy
Adalimumab = dec after 12 weeks Etanercept = going from BIW -> QIW = less therapeutic effect Infiximab = greatest dec symptoms shortest time
35
TNF-alpha inhibitor clinical pearls
combo w/ methotrexate = lower likelihood of resistnace $$$$$ Dont sue w/ live vaccines as immune response can be compromised
36
Otezla (Apremilast)
PDE-4 inhibitor, inhibit TNF-a production ADR mental = depression, suicidial ideation, mood changes = probs dont use Titrate up to 30mg BID, reduce dose if CrCl < 30
37
Otezla (Apremilast) Efficacy & Peals
appears to be less effective than TNF-a inhibitor Oral admin w/ minimal DI and ADR GI concern
38
IL-17 inhibitors
Cosentyx (Secukinumab) Taltz (Ixekizumab) Siliq (Brodalumab)
39
IL-12/23 inhibitors
Stelara (Ustekinumab) Tremfya (Guselkumab) Illumya (Tildrakizumab) Skyrizi (Risankizumab)
40
Cosentyx (Secukinumab) info
Possible anaphylaxis and inc in infection rate Greater efficacy for mod/severe plaque psoriasis than ustekinumab Less long-term efficacy than guselkumab Dosed: QW for 4 weeks, then Q monthly
41
Taltz (Ixekizumab) info
Dosed Q2 wks for 12 wks, then Q4wks SE: neutropenia More efficacy than etanercept
42
Siliq (Brodalumab)
Dosed: QWkly X 3, then Q2weeks REMS for suicidal ideation & Box warning** higher likelihood of complete remission than ustekinumab SE: arthralgia, suicidal ideation, cryptococcal meningitis, candida infections
43
Stelara (ustekinumab) info
efficacy persistent over time May worsen PsA for some pts More major CV events reported**
44
Tremfya (Guselkumab)
SE: tinea, HSV infection effective pts who had inadequate responses to ustekinumab
45
Alumna (Tildrakizumab)
Dosed: week 0/4 nd then every 12 superior to etanercept antibody development w/ minimal impact on efficacy
46
Skyrizi (Risankizumab)
Dosed week 0/4 and then every 12 greater efficacy than ustekinumab and adalimumab higher likelihood of antibody development effecting efficacy
47
IL inhibitor general info
All shown efficacy over etanercept but $$
48
Acitretin info
oral retinoid utilized for sever psoriasis can be used with UVB or PUVA therapy or topical calcipqotriol Less effective used alone Efficacy dose dependent, 50mg optimal Bunch of ADRs, BW
49
Acitretin pregnancy info
Category X pregnancy contraindicated for 3 years after D/c No blood donations from men/women for atleast 3 years after
50
Acitretin in females of child-bearing age
two negative preg test repeat test monthly during therapy, Q3 months 3yrs after therapy 2 forms of Birth control starting 1 month before and 3 years after therapy cant drink during therapy and 2 months after D/c
51
Acitretin in females of child-bearing age
two negative preg test repeat test monthly during therapy, Q3 months 3yrs after therapy 2 forms of Birth control starting 1 month before and 3 years after therapy cant drink during therapy and 2 months after D/cMethotrexate info
52
Methotrexate info
Should be given with folic acid sup daily** more effective than acitretin, similar to cyclosporine w/ less ADR given Weekly BW, Preg X, and 6 months females and 3 months before conception...both have to use contraception CI in Breastfeeding too
53
Mild-moderate psoriasis treatment algorithm
1. Mild to mod TCS 2. trial of topical Vit D analog or retinoid alone or w/ TCS..combo recommended 3. Trial of phototherapy or oral systemic agent 4. consider moderate-severe disease therapy Step down therapy to lowest therapy that maintains control of symptoms
54
Moderate to severe psoriasis treatment algorithm
1. high-V high potency TCS + vitamin D analog/retinoid 2. Add systemic agent ( IL/TNF-a I) to topical therapy or consider trial of phototherapy 3. inc systemic agent potency or use 2 systemic agents in addition to topical therapy 4. use BRM an other agents as needed Step down therapy to lowest therapy that maintains control of symptoms
55
Exampels of BRM
Biologic Response modifiers Acitretin, Methotrexate, Cyclosporine
56
Two main fungi that cause human disease
Dermatophytes Candida albicans
57
Risk factors to mycotic infections of skin, hair and nails
prolonged exposure to sweat maceration intertriginous folds sharing personal belongings occlusion of the skin close living quarters immunodeficiency and suppresion diabetes obesity poor hygiene trauma warm or humid climate
58
Tinea pedis
Athletes foot usually 3/4 or 4/5th toes usually seen in 1 foot and respond to topical therapy
59
Treatment for mild/acute cases of tines pedis
cream generally Terbinafine better than azaleas Treat for 1-6 weeks avoid nystatin**
60
oral treatment of tinea pedis
oral treatments terbinafine 250 QD for 2 weeks Itraconazole 200mg BID X 1 week fluconazole 150mg weekly for 2-6 weeks
61
Tinea unguium
aka onychomycosis fungal infection of nail, more common toe nails
62
Risk factors for Tinea Unguium
> 40yrs old Family history Immunodeficiency Psoriasis Diabetes PVD Tinea pedis Sporting activities
63
Distal sublingual onychomycosis (DSO)
most common T.rubum common cause nail plate, bed and maybe matrix effected white, yellowish or brown discoloration
64
White superficial onychomycosis (WSO)
t.metagrophytes most common cause localized to surface of nail place
65
Proximal sublingual onychomycosis (PSO)
invades nail through proximal nail fold and spreads to nail plate and matrix uncommon in general pop, mostly immunocompromised patients
66
Topical medications approved for onychomycosis
Jublia Kerydan Penlac
67
Penlac (Ciclopirox 8%)
mild-moderate onychomycosis Early stages of DSO Treatment for 1yr only superficial Limited to 3-4 nails used if Systemic therapy is CI
68
systemic treatment of onychomycosis
Terbinafine or itraconazole generally 3 months 12 weeks for toenails or 6 weeks for fingernails
69
Tinea cruris
jock itch scaly, erythematous margin more common males source of infection is almost always patients feet
70
Tinea cruris txm
topical therapy is recommended for 1-2 weeks after system resolution severe/resistn require oral therapy relief of itching/burning can be facilitated by using short-term topical steroids
71
Tinea corporis
ringworm of the body commonly in obese, adults in warmer climates, day care kids
72
Tinea corporis appearance
small, circular, erythematous scaly areas may have pustules may be itchy
73
Tinea corporis treatments
topical agents usually systemic for severely immunocompromised, griseofulvin preferred in children (has penicillin so if allergic cant use)
74
Tinea capitis
Typically occurs in childhood one or more patches of partial hair loss more common in black females
75
Tinea Capitis therapy
depends on causative organism PO therapy for 4-12 wks depending on agent used
76
If Tinea Capitis Microsporum Canis confirmed or unknown
1st = Griseofulvin (6-12weeks) 2nd = Terbinafine, itraconazole, fluconazole
77
If Tinea Capitis Trichophyton tonsurans confirmed
1st = Terbinafine (2-4wks), 6 weeks if granule formation 2nd = Griseofulvin, itraconazole, fluconazole Family members maybe asymptomatic = use antifungal shampoo for at least 5 min, 3 times per week
78
Pityriasis Versicolor
Also called tines versicolor more common in adults and those in tropical temps
79
Pityriasis Versicolor therapy
1st line = Ketoconazole or selenium sulfide Topical Terbinafine maybe used Hypopigmented areas take longer to regiment
80
Pityriasis Versicolor therapy duration
Usually 2-3 weeks Ketoconazole = QD 2-3weeks, let sit for 5min then wash off Selenium sulfide = apply 10min, wash off for 7 days
81
systemic treatment of Pityriasis Versicolor
itraconazole and fluconazole are effective and preferred keto works but dont want to work terbinafine and griseofulvin not effective
82
Goals of therapy for fungal infections
Reduce and or relieve symptoms Eradicate fungus Prevent future infections Prevent spreading of infections
83
Counseling points for fungal infections
reduce moisture to affected area avoid tight fitting clothing keep areas clean dry areas completely wash infected clothing separately avoid walking barefoot in communal areas keep nails short and clean avoid sharing personal items use separate towels to dry off affected area
84
Exclusions for self care
Tinea unguium or Capitis uncealer etiology signs of 2ndary infection involvement of face, genitalia, or mucous membranes if topical doesn't work diabetes, systemic infection or immunodeficiency
85
When to choose cream
better coverage because rubbed into skin product needs to be dried before putting socks on
86
When to choose powder
good for excessive wetness good for skin folds where moisture accumulates
87
When to choose solution
better coverage of affected areas like creams dries more rapidly but more expensive
88
When to choose spray
easy to apply, especially hard to reach Not as effective due to no rubbing